Kamada (KMDA) Operating Leases (2018 - 2026)
Kamada (KMDA) posted quarterly Operating Leases of $9.4 million for Q1 2026, up 1.34% year-on-year from $9.3 million in Q1 2025, and little changed on a QoQ basis from $9.4 million in Q4 2025.
Kamada (KMDA) Operating Leases (2018 - 2026) Analysis & Trends
Kamada (KMDA) has reported Operating Leases for 9 consecutive years, with $9.4 million the latest figure, recorded in Q1 2026.
- Quarterly Operating Leases rose 1.34% year-over-year to $9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.4 million (up 1.34% YoY) and the FY2025 annual result came in at $9.4 million, changed 0.1% from the prior year.
- Operating Leases steadied at $9.4 million in Q1 2026 per KMDA's latest filing, from $9.4 million in the prior quarter.
- Over the last five years, Operating Leases for KMDA reached as high as $9.6 million in Q3 2024 and fell as low as $2414.0 in Q3 2022.
- A 5-year average of $6.2 million and a median of $7.3 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases sank 99.93% — and 2023, when it jumped 195301.82%.
- Year by year, Operating Leases stood at $2.2 million in 2022, then soared by 241.66% to $7.4 million in 2023, then grew by 26.79% to $9.4 million in 2024, then climbed by 0.1% to $9.4 million in 2025, then gained by 0.03% to $9.4 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $9.4 million, $9.4 million, and $9.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.44 Mn |
| Dec 31, 2025 | 9.44 Mn |
| Sep 30, 2025 | 9.56 Mn |
| Jun 30, 2025 | 9.55 Mn |
| Mar 31, 2025 | 9.32 Mn |
| Dec 31, 2024 | 9.43 Mn |
| Sep 30, 2024 | 9.57 Mn |
| Jun 30, 2024 | 7.07 Mn |
| Mar 31, 2024 | 7.28 Mn |
| Dec 31, 2023 | 7.44 Mn |
| Sep 30, 2023 | 4.72 Mn |
| Jun 30, 2023 | 4.97 Mn |
| Mar 31, 2023 | 4,992.00 |
| Dec 31, 2022 | 2.18 Mn |
| Sep 30, 2022 | 2,414.00 |
| Jun 30, 2022 | 2.49 Mn |
| Mar 31, 2022 | 3.06 Mn |
| Dec 31, 2021 | 3.16 Mn |
| Sep 30, 2021 | 3.28 Mn |
| Jun 30, 2021 | 3.40 Mn |